American Healthcare REIT, Inc. (BMV:AHR)
Mexico · Delayed Price · Currency is MXN | Market Cap | 217.38B +61.3% |
| Revenue (ttm) | 43.77B +16.9% |
| Net Income | 2.11B |
| EPS | 11.58 |
| Shares Out | n/a |
| PE Ratio | 102.80 |
| Forward PE | 64.54 |
| Dividend | 17.94 (2.00%) |
| Ex-Dividend Date | Jun 30, 2026 |
| Volume | 13 |
| Open | 897.00 |
| Previous Close | 890.40 |
| Day's Range | 897.00 - 897.00 |
| 52-Week Range | 890.40 - 897.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 6, 2026 |
About American Healthcare REIT
American Healthcare REIT, Inc., a Maryland-based self-managed REIT, owns and operates a diversified portfolio of clinical healthcare real estate across the U.S., U.K., and the Isle of Man. Its focus includes senior housing, skilled nursing facilities (SNFs), outpatient medical (OM) buildings, and other healthcare-related properties. The company utilizes a fully integrated management platform and operates senior housing under the RIDEA structure. In addition to owning and operating properties, it has originated and acquired secured loans and may... [Read more]
News
American Healthcare REIT price target raised to $66 from $61 at Barclays
Barclays analyst Richard Hightower raised the firm’s price target on American Healthcare REIT (AHR) to $66 from $61 and keeps an Overweight rating on the shares. The firm adjusted targets…
American Healthcare REIT price target raised to $68 from $58 at KeyBanc
KeyBanc raised the firm’s price target on American Healthcare REIT (AHR) to $68 from $58 and keeps an Overweight rating on the shares. The firm is also increasing its 2026…
American Healthcare REIT price target raised to $71 from $67 at BofA
BofA analyst Farrell Granath raised the firm’s price target on American Healthcare REIT (AHR) to $71 from $67 and keeps a Buy rating on the shares. The outlook remains most…
American Healthcare REIT price target raised to $65 from $55 at Citi
Citi analyst Seth Bergey raised the firm’s price target on American Healthcare REIT (AHR) to $65 from $55 and keeps a Buy rating on the shares post the Q2 report.
American Healthcare REIT price target raised to $61 from $56 at RBC Capital
RBC Capital raised the firm’s price target on American Healthcare REIT (AHR) to $61 from $56 and keeps an Outperform rating on the shares after its Q2 results. The company…
American Healthcare REIT price target raised to $61 from $57 at Truist
Truist raised the firm’s price target on American Healthcare REIT (AHR) to $61 from $57 and keeps a Buy rating on the shares. The firm is increasing its earnings estimates…
American Healthcare REIT 13.25M share Spot Secondary priced at $53.75
The deal range was $53.75-$54.75. Morgan Stanley, Citi and KeyBanc acted as joint book running managers for the offering.
American Healthcare REIT Announces Pricing of Public Offering of Common Stock
IRVINE, Calif.--(BUSINESS WIRE)--American Healthcare REIT, Inc. (NYSE: AHR; the “Company”) announced today the pricing of an underwritten public offering of 13,250,000 shares of its common stock, all ...
American Healthcare REIT 13.25M share Spot Secondary; price range $53.75-$54.75
Morgan Stanley, Citi and KeyBanc are acting as joint book running managers for the offering.
American Healthcare REIT 13.25M share price range $53.75-$54.75
Morgan Stanley, Citi and KeyBanc are acting as joint book running managers for the offering.
American Healthcare REIT announces offering of 13.25M shares of common stock
American Healthcare REIT (AHR) announced that it has commenced an underwritten public offering of 13.25M shares of its common stock. Morgan Stanley, Citigroup and KeyBanc Capital Markets are acting as...
American Healthcare REIT Announces Public Offering of Common Stock
IRVINE, Calif.--(BUSINESS WIRE)-- #AHR--American Healthcare REIT, Inc. (NYSE: AHR; the “Company”) announced today that it has commenced an underwritten public offering of 13,250,000 shares of its comm...
American Healthcare REIT Earnings Call Transcript: Q2 2026
Q2 2026 delivered double-digit same-store NOI growth for the 10th straight quarter, with normalized FFO per share up 28.6% year-over-year and full-year guidance raised. Over $1.4 billion in acquisitions closed YTD, net debt to EBITDA improved to 2.5x, and the company continues to focus on scaling its senior housing platform.
American Healthcare REIT Earnings release: Q2 2026
American Healthcare REIT released its Q2 2026 earnings on August 7, 2026, summarizing the period's financial results.
American Healthcare REIT Quarterly report: Q2 2026
American Healthcare REIT has published its Q2 2026 quarterly earnings report on August 7, 2026.
American Healthcare REIT reports Q2 normalized FFO 54c, consensus 52c
Reports same-store net operating income growth of 13.2% for the three months ended June 30. The company said, “Our results this quarter reflect a deliberate strategy: concentrate capital in senior…
American Healthcare REIT raises 2026 normalized FFO outlook to $2.15-$2.19
Prior outlook $2.03-$2.09. The company said, “With strong results in the first half and expectation of carrying that momentum through the second half we are raising full-year guidance for both…
American Healthcare REIT Announces Second Quarter 2026 Results; Increases Full Year 2026 Guidance
IRVINE, Calif.--(BUSINESS WIRE)-- #CA--American Healthcare REIT, Inc. (NYSE: AHR) (the “Company,” “we,” “our,” “us,” “management,” or "AHR") is announcing today its second quarter 2026 results and inc...
American Healthcare REIT price target raised to $65 from $60 at Citizens
Citizens raised the firm’s price target on American Healthcare REIT (AHR) to $65 from $60 and keeps an Outperform rating on the shares. American Healthcare REIT remains the firm’s top…
American Healthcare REIT Announces Leadership Appointments
IRVINE, Calif.--(BUSINESS WIRE)--American Healthcare REIT, Inc. (NYSE: AHR) (the “Company”) today announced leadership appointments that build on a decade of stability while accelerating the Company's...
American Healthcare REIT initiated with a Buy at Compass Point
Compass Point analyst Rob Simone initiated coverage of American Healthcare REIT (AHR) with a Buy rating and $70 price target
American Healthcare REIT price target raised to $63 from $60 at UBS
UBS raised the firm’s price target on American Healthcare REIT (AHR) to $63 from $60 and keeps a Buy rating on the shares.
American Healthcare REIT initiated with an Overweight at Barclays
Barclays analyst Richard Hightower initiated coverage of American Healthcare REIT (AHR) with an Overweight rating and $61 price target While initiating coverage of six healthcare REITs, the analyst te...
American Healthcare REIT Announces Dates for Second Quarter 2026 Earnings Release and Conference Call
IRVINE, Calif.--(BUSINESS WIRE)-- #AHR--American Healthcare REIT, Inc. (the “Company”) (NYSE: AHR) announced today that it will issue its second quarter 2026 earnings release on Thursday, August 6, 20...
American Healthcare REIT upgraded to Buy from Neutral at Citi
Citi analyst Seth Bergey upgraded American Healthcare REIT (AHR) to Buy from Neutral with an unchanged price target of $55. the stock’s underperformance versus peers year-to-date creates an attractive...